News › Defence  ·  2 Jul 2026, 4:44 PM IST  ·  14 days ago

Indian Market Range-Bound: Defence, Finance, Pharma Offer

Bias: Bullish +3585% confidenceDefenceFinancial Services

In one line — Maintain a bullish bias on select mid-cap pharma stocks, focusing on companies with strong R&D and USFDA approvals.

Bearish
Bullish
−1000+35+100

Source: Mint · AI-summarised by Anadi · Updated 2 Jul 2026, 5:31 PM IST

Defencewatching
Financial Serviceswatching
Pharmaceuticalswatching

What Happened

Kush Gupta of SKG Investment forecasts a cautious recovery for the Indian stock market in 2026, expecting the broader market to remain range-bound. This expert view provides a medium-term outlook, emphasizing specific sectors that could outperform.

Why It Matters (for you)

This perspective is significant for traders as it suggests a period of consolidation for the overall market, implying that broad-based rallies might be limited. However, it also pinpoints sectors with potential for growth, guiding capital allocation decisions.

Impact on Indian Markets

While no specific stocks are named, the outlook is positive for companies in the Defence, Financial Services, and Pharmaceutical sectors. Traders might consider increasing exposure to ETFs or individual stocks within these sectors, anticipating better performance compared to the broader market.

What Traders Should Watch Next

Traders should monitor macroeconomic indicators closely, as Gupta's prediction is contingent on these factors. Look for specific policy announcements or earnings reports from companies in the identified sectors to confirm the bullish sentiment for these niches.

Key Evidence

  • Kush Gupta, Fund Manager at SKG Investment, predicts a cautious recovery for the Indian stock market in 2026.
  • Gupta expects the broader market to remain range-bound in the medium term.
  • He emphasizes opportunities in defence, financial services, and pharma sectors.
  • Risk flag: USFDA regulatory actions
  • Risk flag: Pricing pressure in key markets